Julia Wang has served as Executive Vice President and Chief Financial Officer of Labcorp since December 2024.

Prior to joining Labcorp, Julia served as CFO of BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235) since 2021, which she joined in 2020 as Senior Vice President, Enterprise Optimization and Deputy CFO. While at BeiGene, she was instrumental in driving business transformations through accelerating growth, nurturing innovation and cultivating a culture of sustainable operating efficiencies.

Julia served as Senior Vice President, Global Business Finance and Corporate Planning at Alexion Pharmaceuticals prior to BeiGene. Before Alexion, she held leadership positions at Quest Diagnostics (NYSE: DGX), including Vice President of Finance, U.S. Regional Business and Enterprise Commercial, and Vice President of Finance, Value Creation. Julia held senior leadership roles at Johnson & Johnson (NYSE: JNJ) as CFO of various operating businesses in medical device and pharmaceuticals earlier in her career. Previously, she led finance initiatives at PepsiCo.

Julia earned her MBA from Fuqua School of Business at Duke University and her BA in British Language and Literature from Shandong Normal University.

Bola Oyegunwa, Ph.D., has served as Labcorp’s Executive Vice President and Chief Information and Technology Officer since November 2024.

Since joining Labcorp in 2019 as Vice President of Decentralized Clinical Trials Technology, Bola has pioneered advancements in remote clinical trial technology, significantly enhancing patient accessibility to trials. He went on to serve as Chief Information Officer for Labcorp’s Drug Development segment, where he led a comprehensive digital transformation, expanded robotic process automation, and developed solutions for investigators and sponsors alike.

In his most recent role as Senior Vice President of Enterprise Systems, Data & Technology, Bola directed essential functions such as laboratory systems, corporate systems, robotics, and data engineering. His leadership delivered transformative technology solutions across Labcorp’s Diagnostics and Biopharma Laboratory Services segments.

Before Labcorp, Bola held leadership positions as Global Head of Virtual Trials Technology and Director of Corporate Strategy at IQVIA, and Global Head of Corporate and Digital Strategy at Cenduit. He has also advised private equity and venture capital firms and served as a board advisor for Headlands Research, a KKR portfolio company.

 Bola holds a Doctorate in Microbiology and Immunology, a Master’s in Microbial Biotechnology, and an MBA from North Carolina State University.